Evidence map›Paper›PMID 30763600›Full record

ArticleHuman immunology2019

High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing.

Gonzalo Montero-Martín, Kalyan C Mallempati, Sridevi Gangavarapu, Francisco Sánchez-Gordo, Maria J Herrero-Mata, Antonio Balas, Jose L Vicario, Florentino Sánchez-García, Maria F González-Escribano, Manuel Muro and 11 more

Abstract read
In one paragraph

Article in Human immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A call to establish HLA registry in Iraq.Journal of Taibah University Medical Sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Identification and characterization of SARS-CoV-2 clusters in the EU/EEA in the first pandemic wave: additional elements to trace the route of the virus.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Gonzalo Montero-MartínDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: gmonter2@stanford.edu.
Kalyan C MallempatiStanford Blood Center, Stanford University School of Medicine, Palo Alto, CA, USA.
Sridevi GangavarapuStanford Blood Center, Stanford University School of Medicine, Palo Alto, CA, USA.
Francisco Sánchez-GordoHistocompatibility, Centro de Transfusión de Málaga, Málaga, Spain.
Maria J Herrero-MataHistocompatibility and Immunogenetics, Banc de Sang i Teixits, Barcelona, Spain.
Antonio BalasHistocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
Jose L VicarioHistocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
Florentino Sánchez-GarcíaImmunology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Maria F González-EscribanoImmunology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Manuel MuroImmunology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Maria R Moya-QuilesImmunology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Rafael González-FernándezImmunology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Javier G Ocejo-VinyalsImmunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Luis MarínMolecular Biology-Hematology, Hospital Clínico Universitario, Salamanca, Spain.
Lisa E CrearyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Kazutoyo OsoegawaStanford Blood Center, Stanford University School of Medicine, Palo Alto, CA, USA.
Tamara VayntrubStanford Blood Center, Stanford University School of Medicine, Palo Alto, CA, USA.
Jose L Caro-OleasHistocompatibility and Immunogenetics, Banc de Sang i Teixits, Barcelona, Spain.
Carlos VilchesImmunogenetics and Histocompatibility, Instituto de Investigación Sanitaria Puerta de Hierro, Madrid, Spain.
Dolores PlanellesHistocompatibility, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain.
Marcelo A Fernández-ViñaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Funding

KIR association studies in neurological diseasesU19NS095774 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERNANDEZ-VINA, MARCELO, OKSENBERG, JORGE R. · 2015 to 2019
$7.0M
NINDS NIH HHS U19 NS095774
6 · The paper itself

Abstract

Next-generation sequencing (NGS) at the HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, -DRB1 and -DRB3/4/5 loci was performed on 282 healthy unrelated individuals from different major regions of Spain. High-resolution HLA genotypes defined by full sequencing of class I loci and extended coverage of class II loci were obtained to determine allele frequencies and also to estimate extended haplotype frequencies. HLA alleles were typed at the highest resolution level (4-field level, 4FL); with exception of a minor deviation in HLA-DPA1, no statistically significant deviations from expected Hardy Weinberg Equilibrium (HWE) proportions were observed for all other HLA loci. This study provides new 4FL-allele and -haplotype frequencies estimated for the first time in the Spanish population. Furthermore, our results describe extended haplotypes (including the less frequently typed HLA-DPA1 and HLA-DQA1 loci) and show distinctive haplotype associations found at 4FL-allele definition in this Spanish population study. The distinctive allelic and haplotypic diversity found at the 4FL reveals the high level of heterozygosity and specific haplotypic associations displayed that were not apparent at 2-field level (2FL). Overall, these results may contribute as a useful reference source for future population studies, for HLA-disease association studies as a healthy control group dataset and for improving donor recruitment strategies of bone marrow registries. HLA genotyping data of this Spanish population cohort was also included in the 17th International Histocompatibility and Immunogenetics Workshop (IHIW) as part of the study of HLA diversity in unrelated worldwide populations using NGS.

Indexed as

Cohort StudiesExonsGene FrequencyGenetic LociGenetic VariationGenotypeHaplotypesHeterozygoteHigh-Throughput Nucleotide SequencingHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHistocompatibility TestingHLA AntigensHomozygoteHumansLinkage DisequilibriumHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensHuman Leukocyte Antigen (HLA)Next-Generation Sequencing (NGS)Population studySpain

Identifiers

PMID30763600
PMCPMC6599556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.